The GLP-1 Crackdown, Microdosing, and the Future of Metabolic Health with Dr. Dean Jones

About this video

Woodward interviews Dr. Dean Jones about his clinical experience with GLP-1 peptides and recent regulatory changes in the research peptide industry. Jones describes his personal weight management journey and claims GLP-1s helped him maintain results with less effort than traditional methods. They discuss Jones’s evolved perspective on long-term peptide use, his reported observations with retatrutide versus tirzepatide in patients, and the January 2026 enforcement actions that shut down many research peptide suppliers.

Key takeaways

• Jones argues that GLP-1 peptides provide appetite suppression that makes weight maintenance easier compared to willpower alone, and he reports using them once or twice monthly himself
• Jones claims retatrutide may offer additional fat-burning effects through glucagon activation but warns it could exacerbate heart arrhythmias and requires medical supervision
• According to Jones, U.S. regulatory agencies sent enforcement letters in late 2025 that caused many research peptide companies to shut down by December 31, 2025, particularly those selling GLP-1s

Episode details: published August 21, 2026 · 23 views · 31:59 long. Summary written by Self Growth Videos from the episode itself. The hormone and peptide concepts described are Jennifer Woodward’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Jennifer Woodward sells a Peptides for Practitioners certification.

← Previous: Using Peptides Safely for Hormones and Fertility with Taylor Williams · Next: What Peptides Works for Women, What Doesn’t, and Where to Start with Tina Haupert, FDN-P →

All Jennifer Woodward videos · Jennifer Woodward profile · Jennifer Woodward Nutrition on YouTube